Table 2 Patient laboratory findings
Laboratory tests |  | UC-MSC (n = 11) | Placebo (n = 6) | p value |
|---|---|---|---|---|
Blood count | Total lymphocyte (µL) | 737 ± 299.55 | 1652.33 ± 2032.80 | 0.01 |
|  | Leukocytes (µL) | 10,959.73 ± 4591.77 | 9605 ± 3998.52 | n.s |
|  | Neutrophils (µL) | 9899.73 ± 4354.47 | 8266 ± 3671.02 | n.s |
|  | Hemoglobin (µL) | 13.35 ± 1.69 | 12.68 ± 2.56 | n.s |
|  | Hematocrit (%) | 41 ± 5 | 38 ± 7 | n.s |
|  | Platelets (µL) | 271,690.91 ± 75,889.73 | 296,500 ± 54,013.89 | n.s |
Serologic | D-Dimer (mg/L) | 7.75 ± 10.81 | 6.45 ± 4.83 | n.s |
|  | C-Reactive protein (mg/dL) | 38 ± 81 | 9 ± 5 | n.s |
|  | Ferritin (ng/mL) | 2760.53 ± 3167.67 | 1600.38 ± 1258.86 | n.s |
|  | Troponin I (pg/mL) | 218 ± 655 | 132 ± 209 | n.s |
Biochemical | Creatinin (mg/dL) | 2.07 ± 1.71 | 1.92 ± 1.84 | n.s |
|  | ALT (µ/L) | 49 ± 40 | 29 ± 14 | n.s |
|  | AST (µ/L) | 60 ± 33 | 45 ± 19 | n.s |
|  | Total Bilirubin (mg/dL) | 0.84 ± 1.41 | 0.33 ± 0.12 | n.s |
|  | Direct bilirubin (mg/dL) | 0.59 ± 1.17 | 0.18 ± 0.06 | n.s |
|  | Indirect bilirubin (mg/dL) | 0.24 ± 0.28 | 0.15 ± 0.10 | n.s |
Main lymphocytes subgroups | TCD3 | 242.17 ± 176.44 | 471.90 ± 205.33 | 0.02 |
|  | TCD4 | 195.120 ± 94.84 | 346.06 ± 194.50 | 0.01 |
|  | TCD8 | 105.83 ± 85.91 | 107.06 ± 41.42 | n.s |
|  | B | 90.47 ± 53.31 | 143.56 ± 146.16 | n.s |
|  | NK | 56.54 ± 35.54 | 41.92 ± 27.21 | n.s |
|  | Treg | 11.26 ± 6.20 | 21.57 ± 6.66 | n.s |
|  | Plasmablasts | 17.04 ± 17.01 | 14.94 ± 7.88 | n.s |